6-Aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (7), 1745-1749
- https://doi.org/10.1016/j.bmcl.2004.01.037
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Active Site Binding Modes of HIV-1 Integrase InhibitorsJournal of Medicinal Chemistry, 2000
- Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in CellsScience, 2000
- Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug designProceedings of the National Academy of Sciences, 1999
- Chicoric Acid Analogues as HIV-1 Integrase InhibitorsJournal of Medicinal Chemistry, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Combination therapy for HIV: the effect on inpatient activity, morbidity and mortality of a cohort of patientsInternational Journal of STD & AIDS, 1998
- Design and discovery of HIV-1 integrase inhibitorsDrug Discovery Today, 1997
- Clinically effective HIV-1 protease inhibitorsDrug Discovery Today, 1997
- Cell protein cross-linking by erbstatin and related compoundsBiochemical Pharmacology, 1996
- Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV InfectionsJournal of Medicinal Chemistry, 1995